FDA Drug Application (020131) for PROHANCE by BRACCO

Back to FDA Applications sponsored by BRACCO

Application Number020131
Product Number001
FormINJECTABLE;INJECTION
Dosage279.3MG/ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePROHANCE
Active IngredientGADOTERIDOL



Back to FDA Applications sponsored by BRACCO

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.